The feasibility of including human papillomavirus vaccine in Iran's national immunization program

Abstract

AimCervical cancer is the second most common form of cancer in women. In order to prevent this disease, several vaccines like Cervarix [2vHPV], Cecolin, Cervarix quadrivalent and Gardasil [9vHPV]), have been included in the vaccination program of some countries. This study as a part of Health Technology Assessment (HTA), aimed to assess the feasibility of inclusion of Human Papilloma Virus (HPV) vaccine in the national vaccination program of Iran. Subject and methodsThis is a qualitative case study composed of semi structured interviews with a purposive sample of experts working extensively in the field of women's health. Data saturation reached at the 12th interview. The data was analyzed using the framework method. ResultsA total of 14 subthemes under 6 themes of the need for vaccines, lack of knowledge, cost factors, administration at early ages, creating a negative mindset, and empowering the society were identified. ConclusionIncluding HPV vaccine in the national vaccination program not only seems justifiable, but also its absence in the vaccination program violates some aspects of medical ethics principles. Therefore, the government must take steps to increase public awareness about human papillomavirus and include the aforementioned vaccine in the national vaccination program.